|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1700 CAD | -8.11% |
|
-5.56% | -19.05% |
| Dec. 31 | Innocan Pharma Closes Private Placement for $635,444 | MT |
| Dec. 30 | InnoCan Pharma Corporation announced that it has received CAD 0.635445 million in funding | CI |
Executive Committee: InnoCan Pharma Corporation
| Manager | Positions heldSince | ||||||
|---|---|---|---|---|---|---|---|
![Iris Bincovich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>) Iris Bincovich |
| ||||||
Nir Avram 72 year |
| ||||||
Eyal Flom 60 year |
| ||||||
Nelson Halpern |
| ||||||
Roni Kamhi |
| ||||||
Eyal Kalo |
|
Composition of the Board of Directors: InnoCan Pharma Corporation
| Director | CommitteesSince | ||||
|---|---|---|---|---|---|
Ron Abraham Mayron 60 year |
| ||||
Eyal Flom 60 year |
| ||||
Joshua Lintern 38 year |
| ||||
Peter Bloch 65 year |
| ||||
Ralph Bossino |
| ||||
Iris Bincovich |
|
Latest Appointments: InnoCan Pharma Corporation
Former Officers and Directors: InnoCan Pharma Corporation
| Insider | Positions held SinceUntil | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
|
Age distribution of managers
Parity Men Women
| Male | 10 |
|---|---|
| Female | 1 |
Of which Executive Committee
| Male | 5 |
|---|---|
| Female | 1 |
Of which Directors
| Male | 5 |
|---|---|
| Female | 1 |
